בוקולאם 2.5 מ"ג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
MIDAZOLAM AS HYDROCHLORIDE 2.5 MG
Available from:
NEOPHARM CURE (2005) LTD
ATC code:
N05CD08
Pharmaceutical form:
OROMUCOSAL SOLUTION
Administration route:
BUCCAL
Manufactured by:
SCM PHARMA LIMITED, UK
Therapeutic group:
MIDAZOLAM
Therapeutic indications:
Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
Authorization date:
2013-05-01
